The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-75
SponsorWestlake University

About this trial

Food plays a crucial role in determining blood glucose levels, especially in people with type 2 diabetes. Precision nutrition, which involves individually tailored dietary interventions, can be a powerful tool in managing blood glucose levels in people with type 2 diabetes. Previous studies found that changes in gut microbiota resulted from the dietary intervention, such as plant-based diet, might subsequently lead to different glycemic responses, and then different health outcomes.

In this study, the investigators will characterize the blood glucose dynamics and gut microbiota of individuals with type 2 diabetes. They aim to assess the influence of plant-based diet on gut microbiota; they will also investigate the influence of gut microbiota on glycemic responses. Additionally, a series of individual N-of-1 trails will be integrated to compare the effects of a white bread breakfast and a whole wheat bread breakfast on glucose metabolism at the individual level.

Eligibility criteria

Qualifiers

Diagnosed with type 2 diabetes;

Living in Hangzhou for at least five years;

Have the willingness or ability to complete the intervention and sample collection

Disqualifiers

Mental and physical disability;

Already is a vegetarian;

Cancer and serious complications from type 2 diabetes, such as renal failure;

Using insulin for more than 5 years;

Trial design

Treatments tested in this trial

  • White bread
  • Whole wheat bread
  • Plant-based diet
  • Conventional diabetic diet
  • Follow-up visit every 1-2 years

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Westlake University

Lead sponsor

The Third People's Hospital of Hangzhou

Collaborator